-+ 0.00%
-+ 0.00%
-+ 0.00%

Estimating The Intrinsic Value Of Human Technologies, Inc. (TSE:5621)

Simply Wall St·12/23/2025 22:51:48
Listen to the news

Key Insights

  • Human Technologies' estimated fair value is JP¥2,165 based on 2 Stage Free Cash Flow to Equity
  • With JP¥1,874 share price, Human Technologies appears to be trading close to its estimated fair value
  • Peers of Human Technologies are currently trading on average at a 309% premium

Does the December share price for Human Technologies, Inc. (TSE:5621) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by taking the expected future cash flows and discounting them to today's value. The Discounted Cash Flow (DCF) model is the tool we will apply to do this. There's really not all that much to it, even though it might appear quite complex.

We generally believe that a company's value is the present value of all of the cash it will generate in the future. However, a DCF is just one valuation metric among many, and it is not without flaws. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model.

Is Human Technologies Fairly Valued?

We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. In the first stage we need to estimate the cash flows to the business over the next ten years. Seeing as no analyst estimates of free cash flow are available to us, we have extrapolate the previous free cash flow (FCF) from the company's last reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.

A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we need to discount the sum of these future cash flows to arrive at a present value estimate:

10-year free cash flow (FCF) forecast

2026 2027 2028 2029 2030 2031 2032 2033 2034 2035
Levered FCF (¥, Millions) JP¥976.2m JP¥1.06b JP¥1.13b JP¥1.19b JP¥1.23b JP¥1.26b JP¥1.29b JP¥1.31b JP¥1.33b JP¥1.34b
Growth Rate Estimate Source Est @ 12.73% Est @ 9.09% Est @ 6.54% Est @ 4.76% Est @ 3.51% Est @ 2.64% Est @ 2.03% Est @ 1.60% Est @ 1.30% Est @ 1.09%
Present Value (¥, Millions) Discounted @ 6.5% JP¥917 JP¥939 JP¥939 JP¥924 JP¥898 JP¥866 JP¥829 JP¥791 JP¥753 JP¥714

("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = JP¥8.6b

We now need to calculate the Terminal Value, which accounts for all the future cash flows after this ten year period. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (0.6%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 6.5%.

Terminal Value (TV)= FCF2035 × (1 + g) ÷ (r – g) = JP¥1.3b× (1 + 0.6%) ÷ (6.5%– 0.6%) = JP¥23b

Present Value of Terminal Value (PVTV)= TV / (1 + r)10= JP¥23b÷ ( 1 + 6.5%)10= JP¥12b

The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is JP¥21b. In the final step we divide the equity value by the number of shares outstanding. Relative to the current share price of JP¥1.9k, the company appears about fair value at a 13% discount to where the stock price trades currently. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent.

dcf
TSE:5621 Discounted Cash Flow December 23rd 2025

The Assumptions

Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Human Technologies as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 6.5%, which is based on a levered beta of 1.123. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

View our latest analysis for Human Technologies

SWOT Analysis for Human Technologies

Strength
  • Currently debt free.
  • Dividends are covered by earnings and cash flows.
Weakness
  • Earnings growth over the past year underperformed the Software industry.
  • Dividend is low compared to the top 25% of dividend payers in the Software market.
Opportunity
  • Annual earnings are forecast to grow faster than the Japanese market.
  • Good value based on P/E ratio and estimated fair value.
Threat
  • No apparent threats visible for 5621.

Looking Ahead:

Whilst important, the DCF calculation ideally won't be the sole piece of analysis you scrutinize for a company. The DCF model is not a perfect stock valuation tool. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. For Human Technologies, we've put together three relevant aspects you should look at:

  1. Risks: Take risks, for example - Human Technologies has 1 warning sign we think you should be aware of.
  2. Future Earnings: How does 5621's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
  3. Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!

PS. Simply Wall St updates its DCF calculation for every Japanese stock every day, so if you want to find the intrinsic value of any other stock just search here.